INVO Fertility, Inc. (IVF) vs Propanc Biopharma, Inc. (PPCB)
A side-by-side comparison of INVO Fertility, Inc. and Propanc Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IVF
INVO Fertility, Inc.
$0.80HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PPCB
Propanc Biopharma, Inc.
$0.49HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IVF vs PPCB
growth of $100 · dividends reinvested · last 10yIVF -100.0% (-58.2%/yr)PPCB -100.0% (-89.4%/yr)IVF compounded faster over this window
Log scale — wide-divergence pair
IVF PPCB
IVF vs PPCB: by the numbers
- •IVF is the larger company ($1M vs $1M market cap).
- •Both run net losses; PPCB's is the smaller (0.00% vs -70.18% net margin).
Metrics side by side
Valuation
| Metric | IVF | PPCB |
|---|---|---|
| P/S ratio | 0.19 | N/A |
| P/B ratio | 0.09 | 0.12 |
Profitability
| Metric | IVF | PPCB |
|---|---|---|
| Gross margin | 33.34% | 0.00% |
| Operating margin | -78.72% | 0.00% |
| Net margin | -70.18% | 0.00% |
| ROE | -32.05% | -200.63% |
| ROIC | -28.43% | -183.49% |
Growth (annualized)
| Metric | IVF | PPCB |
|---|---|---|
| Revenue CAGR (5Y) | 39.51% | N/A |
| Total return CAGR (5Y) | -90.41% | N/A |
Go deeper
Dig into the metrics
INVO Fertility ROEPropanc Biopharma ROEINVO Fertility operating marginPropanc Biopharma operating marginINVO Fertility revenue growthPropanc Biopharma revenue growthINVO Fertility free cash flowPropanc Biopharma free cash flow
INVO Fertility & Propanc Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.